{"filings":[{"id":1387688,"accession_number":"0001826470-26-000047","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-07-01T20:05:17+00:00","items":["5.02","5.07","9.01"],"status":"ready","headline":"Petco shareholders approve 15.5M share increase under 2021 equity plan","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders approved amendment to 2021 Equity Incentive Plan, increasing authorized shares by 15.5 million to 59.3 million total.","All four director nominees (Anderson, Briggs, Chande, Sullivan) elected as Class III directors for three-year terms.","Advisory vote on executive compensation passed with 201.9M for, 42.9M against.","Ratification of Ernst & Young as auditor for fiscal year ending Jan 30, 2027 approved overwhelmingly."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":833756,"accession_number":"0001826470-26-000045","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-06-03T20:10:18+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q1 comps +0.7%, adj. EBITDA $97.3M; reaffirms FY 2026 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales of $1.5B, +0.2% YoY; comparable sales +0.7%, marking return to positive comps.","Gross margin improved 21bps to 38.4%; operating income rose 50.5% to $24.6M.","Adj. EBITDA $97.3M vs $89.4M; net loss widened to $15.1M from $11.7M.","Total debt reduced to $1.482B from $1.593B; cash balance $166.8M.","FY 2026 outlook reaffirmed: net sales flat to +1.5%, adj. EBITDA $415M-$430M; Q2 adj. EBITDA guided $110M-$112M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109295,"accession_number":"0001193125-26-102144","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-03-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco beats profitability goals in FY2025; reduces leverage to 3.0x; provides FY2026 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net sales $1.5B (-2.4% YoY); comps -1.6%; Adjusted EBITDA $106.3M (+10.6%), above outlook.","Full year net sales $6.0B (-2.5%); net income $9.1M vs loss of $101.8M; Adjusted EBITDA $408.2M (+21.3%).","Leverage ratio improved from 4.2x to 3.0x; debt refinanced with $900M term loan and $600M bond, maturities extended to 2031.","FY2026 guidance: net sales flat to +1.5% YoY; Adjusted EBITDA $415M-$430M; Q1 Adjusted EBITDA $92M-$94M.","Free cash flow $187M, up 276.3%; inventory down 9.7%; net store closures ~15-20 for FY2026."],"consensus_eps_estimate":null,"consensus_eps_actual":0.03,"consensus_revenue_estimate":null,"consensus_revenue_actual":5961467000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109294,"accession_number":"0001193125-26-033750","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Petco completes debt refinancing; Glenn Murphy transitions to Chairman of Board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Debt refinancing closed Feb 2; previously announced; aims to reduce leverage and increase financial flexibility.","Glenn Murphy transitions from Executive Chairman to non-employee Chairman of the Board effective Feb 1, 2026.","Murphy receives $9,615.38 lump sum statutory pay and remains eligible for FY2025 annual bonus.","CEO cites strengthened economic model, significant profitability improvement, and improved cash flow."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109293,"accession_number":"0001193125-26-033607","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Petco refi with $900M term loan and $600M 8.25% senior secured notes due 2031","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$900M refinancing term loans at Term Benchmark + 4.25% (0% floor), maturing Feb 2031 with 1% annual amortization.","$600M 8.250% senior secured notes due 2031 issued; proceeds to repay existing term loan facility.","Notes carry covenants limiting additional debt, dividends, investments, asset sales, liens, and affiliate transactions.","Notes redeemable at make-whole premium before Feb 1, 2028; thereafter at specified redemption prices.","Combined proceeds from term loans, notes, and cash on hand used to fully repay existing term loan facility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109292,"accession_number":"0001193125-26-019795","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-01-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco prices $600M 8.25% senior secured notes due 2031 to refinance term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$600M aggregate principal of 8.250% senior secured notes due February 1, 2031.","Closing expected February 2, 2026, subject to customary conditions.","Proceeds, with new term loan and cash, to repay existing term loan, pay fees, and for general corporate purposes.","Notes secured by first-lien on fixed assets and second-lien on current assets.","Notes offered only to QIBs and non-U.S. persons under Rule 144A/Regulation S."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109291,"accession_number":"0001193125-26-017351","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-01-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco announces $650M senior secured notes offering due 2031 to refinance term loan","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$650M aggregate principal of senior secured notes due 2031; guaranteed by Petco's subsidiary guarantors.","Notes secured first-lien on fixed assets and second-lien on current assets.","Proceeds, plus new term loan borrowings and cash, to repay existing term loan facility in full.","Offering conducted under Rule 144A/Reg S; notes not registered under Securities Act.","Completion subject to pricing and customary closing conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":109290,"accession_number":"0001193125-26-009852","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2026-01-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco launches $1.5B debt refinancing, reaffirms FY2025 outlook","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Intends to refinance $1.5 billion of its current term loan to extend maturities; subject to market conditions.","Completed $50M voluntary prepayment in Dec 2025; up to $100M additional authorized by board.","Reaffirms FY2025 Net Sales down 2.5%-2.8%; Adjusted EBITDA $395M-$397M.","Reaffirms Q4 2025 Adj. EBITDA $93M-$95M; Net Sales down low single digits YoY.","CEO cites fiscal 2025 execution and category resilience; no assurances refinancing will be completed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":125784,"accession_number":"0001193125-25-297206","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-11-25T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q3 net sales down 3.1% to $1.5B, adjusted EBITDA up 17% to $98.6M; raises FY2025 adjusted EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.5B, down 3.1% YoY; comparable sales down 2.2% YoY.","GAAP net income of $9.3M, up $26.0M YoY.","Adjusted EBITDA increased $17.3M to $98.6M.","FY2025 adjusted EBITDA guidance raised to $395M-$397M, midpoint increased $6M.","Gross profit margin expanded 75bps to 38.9% of net sales."],"consensus_eps_estimate":null,"consensus_eps_actual":0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":4446339000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142512,"accession_number":"0001826470-25-000010","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q2 net sales down 2.3% YoY, EBITDA up; raises FY2025 earnings outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 net sales $1.5B (-2.3% YoY); comparable sales -1.4%; gross margin expanded 120bps to 39.3%.","GAAP net income $14.0M (improved $38.8M); Adjusted EBITDA $113.9M (+$30.3M).","Full year FY2025 outlook: net sales down low single digits; Adj. EBITDA raised to $385M-$395M; net store closures ~25.","Q3 FY2025 outlook: Adj. EBITDA $92M-$94M; net sales down low single digits.","CEO Joel Anderson: 'first half established solid foundation for transformation; raising earnings outlook.'"],"consensus_eps_estimate":null,"consensus_eps_actual":0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":2981928000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142511,"accession_number":"0001826470-25-000005","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-08-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco to present at Goldman Sachs Global Retailing Conference on Sept. 4, 2025","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Presentation scheduled for Thursday, Sept. 4, 2025 at approximately 1:50 p.m. Eastern Time.","Live webcast available on Petco's investor relations page at ir.petco.com.","Replay will be available through same link approximately two hours after the presentation.","No financial results or guidance were disclosed in this announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":142510,"accession_number":"0000950170-25-099616","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-07-29T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Petco shareholders re-elect three directors, approve executive compensation, ratify EY as auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["R. Michael Mohan: 225.7M votes for (95.8% of votes cast); David Lubek: 213.1M for; Christopher J. Stadler: 207.6M for.","Advisory vote on named executive officer compensation passed with 221.2M for, 14.4M against, 148.5K abstentions.","Ratification of Ernst & Young as independent auditor for FY ending Jan 31, 2026: 254.5M for, 2.3M against, 284K abstentions.","Broker non-votes of 21.4M shares on Proposals 1 and 2; none on Proposal 3."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160550,"accession_number":"0000950170-25-082319","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-06-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q1 net sales down 2.3% to $1.5B; net loss improves to $11.7M; reaffirms FY2025 outlook","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net sales $1.5B, down 2.3% YoY; comparable sales -1.3%; gross margin +30bps to 38.2%.","Operating income improved $33.1M to $16.4M; GAAP net loss improved $34.8M to $11.7M.","Adjusted EBITDA rose $13.8M to $89.4M, ahead of guidance.","Q2 2025 outlook: net sales down low single digits YoY; Adj. EBITDA $92-$94M.","FY2025 outlook reaffirmed: Adj. EBITDA $375-$390M; capex $125-$130M; assumes tariffs at current levels."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.04,"consensus_revenue_estimate":null,"consensus_revenue_actual":1493399000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":160549,"accession_number":"0000950170-25-076991","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Director Christy Lake to resign from Petco Board at 2025 annual meeting; Board size reduced to 10","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Christy Lake resigned from the Board and compensation committee, effective at the 2025 Annual Meeting of Stockholders.","Lake will not stand for re-election; departure is not due to any disagreement with Petco.","Board reduced its size from 11 to 10 directors, effective immediately after the Annual Meeting.","Lake is expected to remain on the Board and compensation committee until the meeting date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178798,"accession_number":"0000950170-25-045204","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-03-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q4 revenue down 7.3% to $1.6B; guides FY25 Adjusted EBITDA $375-390M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 GAAP net loss $13.8M vs loss $22.6M last year; Adjusted EBITDA $96.1M vs $105.3M.","Full-year GAAP net loss $101.8M vs $1.3B loss (incl $1.2B goodwill impairment); revenue $6.1B.","FY25 guidance: Adjusted EBITDA $375-390M (double-digit growth); net revenue down low single digits; 20-30 net store closures.","Q1 FY25 guidance: Adjusted EBITDA $82-83M; net revenue down low single digits YoY; capex $130-140M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":6116462000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178795,"accession_number":"0001193125-25-035119","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K/A","filed_at":"2025-02-25T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Petco CFO Brian LaRose to receive $730K separation payment; transition period ends April 30","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian LaRose succeeded by Sabrina Simmons as CFO effective Feb 17, 2025; remains as non-officer employee through April 30, 2025.","Separation agreement provides lump sum of $730,392 (12 months base salary and COBRA premiums).","Also includes pro-rata 2025 annual incentive and pro-rata retention bonus of $27,945.","LaRose releases all claims; unvested equity forfeited."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178797,"accession_number":"0001193125-25-033440","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-02-24T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Petco CFO Brian LaRose to depart April 30; separation package valued at $730K plus pro-rated incentives","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Brian LaRose steps down as CFO on Feb 17, succeeded by Sabrina Simmons; will serve as non-officer employee through April 30, 2025.","LaRose receives $730,392 lump sum (12 months base salary and COBRA premiums) subject to release.","LaRose also gets pro-rated 2025 annual incentive (prorated through Feb 17) and pro-rated retention bonus of $27,945.","Remains eligible for 2024 annual incentive based on actual performance.","All unvested equity awards forfeited as of separation date; unvested retention bonus forfeited after Transition Date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":178796,"accession_number":"0001193125-25-028619","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Petco appoints Sabrina Simmons as CFO, Michael Romanko as CPO, and Jack Stout as CMO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sabrina Simmons (ex-Gap CFO) named CFO effective Feb 17; she resigned from Board and Audit Committee.","Brian LaRose steps down as CFO and remains in advisory role until April 30, 2025.","Simmons receives $840K base salary, 100% target bonus, $2.5M initial RSUs, and $2M annual equity.","Michael Romanko (ex-Five Below) named Chief Customer and Product Officer effective Feb 24.","Jack Stout (ex-7-Eleven) named Chief Merchandising Officer effective Feb 24, previously served as interim."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":195480,"accession_number":"0000950170-24-133669","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-12-05T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q3 revenue $1.51B (+1.2% YoY); adj EBITDA $81.2M vs $72.2M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Comparable sales +1.8% YoY; consumables +2.7%, services +5.0%, supplies -2.8%.","GAAP net loss $16.7M (-$0.06/share) vs $1.2B loss (-$4.63) prior year due to $1.2B goodwill impairment.","Adjusted net loss $6.5M (-$0.02/share) vs $14.5M loss (-$0.05) prior year.","Adjusted EBITDA $81.2M, up from $72.2M in Q3 last year.","CEO Joel Anderson cites progress on retail fundamentals; expects solid finish to 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.32,"consensus_revenue_estimate":null,"consensus_revenue_actual":4564332000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211738,"accession_number":"0000950170-24-105135","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-09-10T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q2 2024: revenue flat at $1.52B, GAAP net loss $24.8M, adjusted EBITDA down 26%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $1.52B, down 0.5% YoY; comparable sales +0.3% YoY.","GAAP net loss $24.8M ($0.09 loss per share) vs $14.6M loss a year ago.","Adjusted EBITDA $83.5M vs $112.6M; Adjusted net loss $5.9M vs prior-year profit.","Consumables +1.5%, services +3.1%, supplies/companion animal -4.7% YoY.","Operating cash flow $69.4M, free cash flow $42.0M; both declined YoY."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.26,"consensus_revenue_estimate":null,"consensus_revenue_actual":3052895000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211737,"accession_number":"0001193125-24-192842","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-08-02T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Petco names Joel Anderson CEO; Mohan to chair new Value Creation Committee","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joel D. Anderson succeeded R. Michael Mohan as CEO effective July 29, 2024.","Board formed Value Creation Committee; Mohan appointed Chair with $250,000 annual cash fee.","Mohan's RSUs and Options modified so transition tranche vests over 5 months post-transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211736,"accession_number":"0000950170-24-085441","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Petco stockholders elect four Class I directors, approve say-on-pay, ratify EY auditor","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Iris Yen elected with 215.8M votes for; Cameron Breitner 212.5M; Sabrina Simmons 216.0M; Glenn Murphy 214.7M.","Non-binding advisory vote on named executive officer compensation passed: 223.1M for, 8.4M against, 143k abstain.","Ratification of Ernst & Young for fiscal 2025 passed: 247.3M for, 2.3M against, 159k abstain.","All results reflect combined voting of Class A, B-1, and B-2 common stock per their respective entitlements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":211735,"accession_number":"0001193125-24-180399","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-07-17T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Petco appoints Joel D. Anderson as CEO effective July 29, 2024; Mohan returns to board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Joel D. Anderson, former Five Below CEO, named CEO of Petco effective July 29, 2024.","Anderson succeeds R. Michael Mohan, who will chair new board value creation committee.","New CEO compensation: $1.3M base salary, 150% target bonus, $15M in initial equity awards.","Anderson also appointed to Board of Directors, increasing board size to 12."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230478,"accession_number":"0001193125-24-148156","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-05-28T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Petco eliminates COO role; appoints new Chief Stores Officer and Interim Chief Merchant","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Justin Tichy resigns as COO effective June 8, 2024; role eliminated.","Amy College out as Chief Merchandising & Supply Chain Officer; will remain employee through Aug 17, 2024; eligible for severance.","James Roth appointed Chief Stores Officer, reporting to Interim CEO Mike Mohan; former EVP Stores at Abercrombie & Fitch.","Shari White appointed Interim Chief Merchant; previously at Perrigo and Target.","Executive Leadership Team expanded to include heads of planning, digital, services, stores, and merchandising."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230477,"accession_number":"0000950170-24-063278","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-05-22T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco reports Q1 net loss of $46.5M; revenue down 1.7% YoY to $1.5B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss of $46.5M ($0.17 per share) vs. prior year loss of $1.9M ($0.01 per share).","Adjusted net loss of $11.8M ($0.04 per share) vs. prior year income of $14.9M ($0.06 per share).","Adjusted EBITDA fell to $75.6M from $111.0M; operating cash flow was negative $8.4M.","Comparable sales declined 1.2% YoY; supplies and companion animal down 6.8%, services up 4.2%.","Interim CEO Mike Mohan cites focus on retail fundamentals and cost transformation to restore profitability."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.17,"consensus_revenue_estimate":null,"consensus_revenue_actual":1529140000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230476,"accession_number":"0001193125-24-138218","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-05-14T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Petco appoints Glenn Murphy Executive Chairman; he invests $2.5M in stock","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Murphy purchased 1.47M shares at $1.70 via private placement for ~$2.5M; 50% held through 2026, 50% through 2027.","Board expanded to 11; Murphy receives annual base salary of $250K with 100% target bonus.","Inducement awards: 1M RSUs and options for 3.5M-4.25M shares at exercise prices from $2.50 to $10.00, vesting quarterly over 3 years.","Murphy will lead Board search for permanent CEO; brings retail experience from Gap, Shoppers Drug Mart, and Lululemon."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":230475,"accession_number":"0001193125-24-090944","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-04-09T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Petco terminates Chief Customer Officer Darren MacDonald effective April 12","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Darren MacDonald's employment as Chief Customer Officer terminated without cause effective April 12, 2024.","Eligible for separation benefits under Petco's Executive Severance Plan upon signing a release of claims.","Board approved termination; no replacement announced."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248861,"accession_number":"0001193125-24-066384","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-03-13T23:59:59+00:00","items":["2.02","5.02","7.01","9.01"],"status":"ready","headline":"Petco Q4 GAAP loss $0.08/sh, adjusted EPS $0.02; CEO Coughlin out, Mohan interim","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 net revenue $1.7B (+6.1% YoY); comparable sales -0.9%; GAAP net loss $22.6M vs prior-year net income $32.7M.","Full-year GAAP net loss $1.3B (incl. $1.2B goodwill impairment); adjusted EPS $0.09 vs $0.61 prior year.","CEO Ron Coughlin stepped down; Board reduced to 10; R. Michael Mohan appointed interim CEO effective March 13.","Mohan compensation: base $1.1M, target bonus 125%, equity awards $8M with exercise price $5.00.","Coughlin to provide transition services through May 1, then consulting at $107,500/month for 12 months."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":6255284000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":248860,"accession_number":"0000950170-24-019763","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2024-02-26T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco CFO to speak at UBS Consumer & Retail Conference on March 14","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["CFO Brian LaRose will present at UBS Global Consumer and Retail Conference on March 14, 2024.","Fireside chat scheduled for approximately 11:00 a.m. Eastern Time.","Webcast available via Petco's investor relations page; replay archived through March 28."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":266399,"accession_number":"0000950170-23-066548","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-11-29T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco posts Q3 net loss of $1.2B on $1.49B revenue; non-cash impairment charge","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP net loss of $1.2B ($4.63 per share) includes $1.2B non-cash goodwill impairment from 2015.","Net revenue $1.49B, down 0.5% YoY; comparable sales flat YoY but up 4.1% two-year.","Adjusted EBITDA fell to $72.2M from $120.2M YoY; adjusted EPS $(0.05) vs $0.11.","Operating cash flow $34.4M vs $109.4M YoY; free cash flow negative $(28.1)M.","Year-to-date free cash flow $(7.8)M vs $(2.6)M in prior year period."],"consensus_eps_estimate":null,"consensus_eps_actual":-4.71,"consensus_revenue_estimate":null,"consensus_revenue_actual":4580808000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283629,"accession_number":"0000950170-23-048394","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-09-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco CFO and Chief Veterinarian to speak at Evercore ISI Pet Care Summit on Sept 20","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Brian LaRose (CFO) in fireside chat ~11:40 AM ET; Dr. Whitney Miller on pet services panel ~12:30 PM ET.","Webcast available at ir.petco.com; replay archived through Oct 4, 2023.","No financial results or guidance disclosed in the announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283628,"accession_number":"0000950170-23-047294","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-09-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco CEO Ron Coughlin to speak at Goldman Sachs retail conference on Sept 13","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Ron Coughlin (Chairman & CEO) to participate in fireside chat at 30th Annual Goldman Sachs Global Retailing Conference on Sept 13, 2023 at 3:55 p.m. ET.","Live audio webcast available at ir.petco.com; replay available through Sept 27, 2023.","No financial results or guidance disclosed in the announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":283627,"accession_number":"0000950170-23-044238","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-08-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q2 net loss $14.6M vs net income $13.5M a year ago; revenue up 3.4% to $1.53B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Comparable sales grew 3.2% YoY; 19th consecutive quarter of comp sales growth.","Net loss of $14.6M ($0.05 loss per share) vs net income of $13.5M ($0.05 EPS) in prior year.","Adjusted EBITDA fell to $112.6M from $133.5M; adjusted EPS $0.06 vs $0.16.","Operating cash flow improved to $96.6M from $42.6M; free cash flow $44.6M from $(27.7)M.","Revenue of $1.53B up 3.4% YoY on continued services and consumables strength."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":3086642000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303149,"accession_number":"0001193125-23-178719","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-06-29T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Petco appoints Iris Yen and David Lubek to Board following resignations of Pereira and Biagosch","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jennifer Pereira resigned from Board effective June 23, 2023; Maximilian Biagosch resigned effective June 29, 2023, both not due to any disagreement.","Board appointed Iris Yen (VP at Nike) as Class I director and David Lubek (MD at CPP Investments) as Class II director effective June 29, 2023.","Yen appointed to Audit Committee replacing Gary Briggs; Lubek appointed to Nominating and Corporate Governance Committee; Mary Sullivan moves to Compensation Committee.","Annual RSU grant for independent directors increased from $150k to $165k effective July 6, 2023; Yen also receives initial $120k RSU grant.","Yen and Lubek designated by controlling stockholder Scooby Aggregator, LP per Stockholder's Agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303148,"accession_number":"0001193125-23-173967","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-06-23T23:59:59+00:00","items":["3.03","5.03","5.02","5.07","9.01"],"status":"ready","headline":"Petco stockholders approve 15.5M share increase to equity plan and officer liability amendment at annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Stockholders elected Gary Briggs, Nishad Chande, and Mary Sullivan as Class III directors.","Approved increase of shares under 2021 Equity Plan by 15.5M to 43.8M total.","Approved certificate amendment to limit officer monetary liability as permitted by Delaware law.","Advisory say-on-pay passed with 187M for vs 58.8M against.","Ratified Ernst & Young as auditor for FY ending Feb 3, 2024 (256.7M for)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":303147,"accession_number":"0000950170-23-023757","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-05-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q1 revenue up 5.4% to $1.56B, net loss $1.9M, reaffirms FY2023 guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Comparable sales grew 5.1% YoY (18th consecutive quarter); consumables +11.2%, services +25.4%.","Adjusted EPS $0.06 vs $0.14 prior year; adjusted EBITDA $111.0M, down 6.9% YoY.","Net loss of $1.9M ($0.01/sh) vs net income $24.7M ($0.09/sh) prior year, driven by higher interest expense.","Paid down $35M term loan in Q1 and $25M in May; targeting $100M total debt paydown in 2023.","Company reaffirms full year 2023 guidance; remains focused on de-levering balance sheet."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.01,"consensus_revenue_estimate":null,"consensus_revenue_actual":1555908000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322791,"accession_number":"0000950170-23-009043","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-03-22T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q4 revenue up 4.2% to $1.58B; comp sales +5.3%; net income $32.7M","summary_kind":"llm","event_type":"earnings","confidence":"medium","bullets":["Q4 net revenue $1.58B (+4.2% YoY); comparable sales +5.3% (17th consecutive quarter of comp growth).","Q4 net income $32.7M ($0.12 EPS) vs $29.0M ($0.11); adjusted EPS $0.23 vs $0.28.","Full year revenue $6.04B (+3.9%); net income $90.8M ($0.34) vs $164.4M ($0.62); adjusted EBITDA $582.3M (-1.5%).","Q4 operating cash flow $136.5M (+95.7%); free cash flow $70.6M vs negative $5M prior year.","In March 2023, paid down $35M on term loan; targeting $100M total principal payments for 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":0.34,"consensus_revenue_estimate":null,"consensus_revenue_actual":6035967000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":322790,"accession_number":"0000950170-23-000139","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2023-01-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco to present at Needham Growth Conference fireside chat on Jan 11, 2023","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Participating in a fireside chat at the 25th Annual Needham Growth Conference.","Event scheduled for Wednesday, January 11, 2023 at 12:45 p.m. Eastern.","Live audio webcast available on Petco's investor relations page; replay through Jan 26."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340843,"accession_number":"0000950170-22-026686","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-12-16T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Petco amends credit agreements to replace LIBOR with SOFR-based rates","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Both First Lien and ABL credit agreements amended to replace LIBOR with Adjusted Term SOFR plus credit spread adjustments (11.448 bps for 1M, 26.161 bps for 3M, 42.826 bps for 6M).","ABL amendment also corrects section references in definitions of 'Eligible Accounts' and 'Eligible Inventory'.","No changes to principal amounts, maturity dates, or other material terms; no new borrowings.","Amendments effective December 12, 2022, with no lender objections received within the specified notice period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340840,"accession_number":"0001193125-22-297129","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K/A","filed_at":"2022-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco corrects time for Morgan Stanley conference fireside chat to 1:45 p.m. ET","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Fireside chat at Morgan Stanley Global Consumer & Retail Conference rescheduled to Dec 6, 2022 at 1:45 p.m. EST.","Previously announced time was 8:45 a.m. EST; no other changes to participation.","Live webcast available on Petco investor relations page; replay through Dec 20, 2022."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340842,"accession_number":"0000950170-22-025919","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-12-01T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco to participate in Morgan Stanley conference fireside chat on Dec 6","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Company to present at Morgan Stanley Global Consumer & Retail Conference on Dec 6, 2022 at 8:45 a.m. ET.","Live audio webcast available on Petco's investor relations page; replay through Dec 20.","No financial results or business updates provided in the announcement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":340841,"accession_number":"0000950170-22-025835","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-11-30T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q3 net revenue $1.50B (+4.0% YoY); net income falls to $19.9M from $52.8M; reaffirms revenue and EBITDA guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $1.50B (+4.0% YoY); comparable sales up 4.1%, marking 16th consecutive quarter of growth.","Net income $19.9M ($0.07 EPS) vs $52.8M ($0.20) prior year; adjusted EPS $0.16 vs $0.20.","Adjusted EBITDA $137.6M, down $1.0M YoY; operating cash flow $109.4M (+27% YoY).","Reaffirmed FY revenue $5.975B-$6.05B and Adjusted EBITDA $580-595M; updated adjusted EPS guidance to $0.75-$0.79."],"consensus_eps_estimate":null,"consensus_eps_actual":0.22,"consensus_revenue_estimate":null,"consensus_revenue_actual":4458008000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358014,"accession_number":"0001564590-22-033000","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-09-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Petco adopts executive severance plan covering non-CEO officers","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Plan effective Sept 29, 2022; Tier 1: Section 16 officers except CEO; Tier 2: other SVP+ employees.","Severance benefits: lump sum base salary, pro-rated annual bonus (actual performance), COBRA premium payment for 12 months.","Plan cannot be amended or terminated for 24 months after a Change in Control without participant consent.","Severance under the Plan supersedes individual agreements if a participation agreement is signed.","Payment subject to release of claims and continued compliance with confidentiality agreements."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358013,"accession_number":"0001564590-22-031018","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-09-06T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Petco to present at Goldman Sachs Global Retailing Conference on Sept 7","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Presentation at Goldman Sachs 29th Annual Global Retailing Conference on Sept 7, 2022 at 4 p.m. ET.","Live audio webcast available via Petco's investor relations page at ir.petco.com.","Replay archived through September 21, 2022.","No financial results or guidance disclosed in this filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358010,"accession_number":"0001564590-22-030957","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K/A","filed_at":"2022-09-02T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Petco discloses separation agreement with departing officer Michael Nuzzo","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Lump sum cash payment of $1,318,015 covering 18 months base salary, health premiums, and 50% of target FY2022 bonus.","Accelerated vesting of 2,472,055 Common Series C Units in Scooby LP.","Scooby LP waived its call right on Nuzzo's Common Series C and B Units."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358012,"accession_number":"0001564590-22-030014","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-08-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q2 revenue up 3.2% to $1.48B, EPS drops to $0.05 from $0.28 YoY; FY22 guidance updated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net revenue $1.48B (+3.2% YoY); comparable sales +3.8%, marking 15th consecutive quarterly growth.","Net income $13.5M ($0.05 EPS) vs $75.1M ($0.28 EPS) prior year; adjusted EPS $0.19 vs $0.25.","Adjusted EBITDA $142M, down $13.1M YoY; FY22 guidance: revenue $5.975B-$6.05B, Adj EBITDA $580M-$595M.","EPS hit by $55.4M non-cash investment write-down and $10.9M integration costs for Thrive JV buyout."],"consensus_eps_estimate":null,"consensus_eps_actual":0.14,"consensus_revenue_estimate":null,"consensus_revenue_actual":2956788000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":358011,"accession_number":"0001193125-22-216284","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-08-09T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Petco appoints Justin Tichy as COO; Mike Nuzzo to leave company","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Justin Tichy named COO and Chief Pet Care Center Officer effective Aug 8, 2022, succeeding Mike Nuzzo.","Mike Nuzzo steps down as COO and will leave Petco on Aug 13, 2022 after over seven years.","Other appointments: Amy College adds demand planning; Jason Heffelfinger promoted to Chief Services Officer; Darren MacDonald becomes Chief Customer Officer."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376717,"accession_number":"0001564590-22-024882","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-06-30T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Petco annual meeting elects four Class II directors, ratifies auditor, approves executive compensation","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Christy Lake, Mike Mohan, Jennifer Pereira, Christopher Stadler elected as Class II directors with >220M votes for each.","Non-binding advisory vote on named executive officer compensation passed (245.8M for, 0.93M against).","Ratification of Ernst & Young as independent auditor for fiscal year ending Jan 28, 2023 approved (256.0M for, 0.11M against)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376715,"accession_number":"0001193125-22-160244","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K/A","filed_at":"2022-05-26T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q1 net revenue up 4.3% to $1.48B; comp sales +5.1% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net income rose 227% to $24.7M ($0.09 EPS); adjusted EPS $0.17 flat YoY.","Comparable sales grew 5.1% in Q1, marking 14th consecutive quarter of growth.","Full-year guidance reaffirmed: revenue $6.15B-$6.25B, adjusted EBITDA $630M-$645M.","Adjusted EBITDA up 5.4% to $132.6M."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":1475991000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":376716,"accession_number":"0001564590-22-021054","cik":1826470,"company_name":"Petco Health & Wellness Company, Inc.","ticker":"WOOF","form_type":"8-K","filed_at":"2022-05-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Petco Q1 net revenue $1.48B (+4.3% YoY); net income up 227% to $0.09 EPS","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Comparable sales grew 5.1% YoY and 33.5% on a two-year stack; 14th consecutive quarter of growth.","Net income $24.7M ($0.09 EPS) vs $7.6M ($0.03 EPS) prior year; adjusted EPS $0.17 consistent YoY.","Adjusted EBITDA rose 5.4% to $132.6M from $125.8M in Q1 2021.","Full-year FY2022 guidance maintained: revenue $6.15B-$6.25B, adj. EBITDA $630M-$645M, adj. EPS $0.97-$1.00.","Operates over 200 wholly owned veterinary hospitals, supporting services and recurring revenue growth."],"consensus_eps_estimate":null,"consensus_eps_actual":0.09,"consensus_revenue_estimate":null,"consensus_revenue_actual":1475991000.0,"consensus_period":"2022-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":798580000.0,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-05-24T23:59:59+00:00|376716"}